BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Hoang L, Chiang S, Lee C. Endometrial stromal sarcomas and related neoplasms: new developments and diagnostic considerations. Pathology 2018;50:162-77. [DOI: 10.1016/j.pathol.2017.11.086] [Cited by in Crossref: 68] [Cited by in F6Publishing: 74] [Article Influence: 17.0] [Reference Citation Analysis]
Number Citing Articles
1 Hinchcliff E, Lawson B, Fleming ND. Other rare uterine sarcomas: Adenosarcoma, endometrial stromal sarcoma, STUMP. Diagnosis and Treatment of Rare Gynecologic Cancers 2023. [DOI: 10.1016/b978-0-323-82938-0.00010-0] [Reference Citation Analysis]
2 Nucci MR, Webster F, Croce S, George S, Howitt BE, Ip PP, Lee C, Rabban JT, Soslow RA, van der Griend R, Lax SF, Mccluggage WG. Data Set for Reporting of Uterine Malignant and Potentially Malignant Mesenchymal Tumors: Recommendations From the International Collaboration on Cancer Reporting (ICCR). International Journal of Gynecological Pathology 2022;41:S44-S63. [DOI: 10.1097/pgp.0000000000000911] [Reference Citation Analysis]
3 de Almeida BC, Dos Anjos LG, Dobroff AS, Baracat EC, Yang Q, Al-Hendy A, Carvalho KC. Epigenetic Features in Uterine Leiomyosarcoma and Endometrial Stromal Sarcomas: An Overview of the Literature. Biomedicines 2022;10:2567. [PMID: 36289829 DOI: 10.3390/biomedicines10102567] [Reference Citation Analysis]
4 Croce S, Devouassoux-Shisheboran M, Pautier P, Ray-Coquard I, Treilleux I, Neuville A, Arnould L, Just PA, Belda MALF, Averous G, Leroux A, Mery E, Loussouarn D, Weinbreck N, Le Guellec S, Mishellany F, Morice P, Guyon F, Genestie C. Uterine sarcomas and rare uterine mesenchymal tumors with malignant potential. Diagnostic guidelines of the French Sarcoma Group and the Rare Gynecological Tumors Group. Gynecol Oncol 2022:S0090-8258(22)00515-7. [PMID: 36114030 DOI: 10.1016/j.ygyno.2022.07.031] [Reference Citation Analysis]
5 Zhou H, Wang Z. Molecular mechanisms of the Polycomblike family proteins in epigenetic regulation and their biological functions. Sci Sin -Vitae 2022;52:1118-1128. [DOI: 10.1360/ssv-2022-0132] [Reference Citation Analysis]
6 Smith ES, Jansen C, Miller KM, Chiang S, Alektiar KM, Hensley ML, Mueller JJ, Abu-Rustum NR, Leitao MM Jr. Primary characteristics and outcomes of newly diagnosed low-grade endometrial stromal sarcoma. Int J Gynecol Cancer 2022:ijgc-2022-003383. [PMID: 35641004 DOI: 10.1136/ijgc-2022-003383] [Reference Citation Analysis]
7 Kim Y, Kim D, Sung WJ, Hong J. High-Grade Endometrial Stromal Sarcoma: Molecular Alterations and Potential Immunotherapeutic Strategies. Front Immunol 2022;13:837004. [PMID: 35242139 DOI: 10.3389/fimmu.2022.837004] [Reference Citation Analysis]
8 Mayr D, Horn L, Hiller GGR, Höhn AK, Schmoeckel E. Endometriale und weitere seltene uterine Sarkome. Pathologe 2022;43:183-195. [DOI: 10.1007/s00292-022-01072-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Crowley F, Cadoo KA, Chiang S, Mandelker DL, Bajwa R, Iasonos A, Zhou QC, Miller KM, Hensley ML, O'cearbhaill RE. Evaluating the role of aromatase inhibitors in the treatment of low-grade endometrial stromal sarcomas. Gynecologic Oncology Reports 2022;40:100980. [DOI: 10.1016/j.gore.2022.100980] [Reference Citation Analysis]
10 Yoshida H, Kikuchi A, Tsuda H, Sakamoto A, Fukunaga M, Kaku T, Yoshida M, Shikama A, Kogata Y, Terao Y, Tanikawa M, Yasuoka T, Chiyoda T, Miyamoto T, Okadome M, Nakamura T, Enomoto T, Konno Y, Yahata H, Hirata Y, Aoki Y, Tokunaga H, Usui H, Yaegashi N. Discrepancies in pathological diagnosis of endometrial stromal sarcoma: a multi-institutional retrospective study from the Japanese Clinical Oncology Group. Hum Pathol 2022:S0046-8177(22)00073-9. [PMID: 35339567 DOI: 10.1016/j.humpath.2022.03.007] [Reference Citation Analysis]
11 Tskhay V, Bazina M, Levanova E, Khorzhevskii V, Mihaylova A, Mileeva I, Khudyakov A, Füllers U, Rogmans C, Friedrich M. Endometriales Low-Grade-Stromasarkom als Zufallsbefund bei sonografischem Verdacht auf ein degenerativ verändertes Myom in der Schwangerschaft. Geburtshilfe Frauenheilkd 2022;82:282-6. [DOI: 10.1055/a-1553-8425] [Reference Citation Analysis]
12 Bai H, Yuan F, Liang B, Sun H, Gao Y, Jin M, Xing X. Clinicopathological characteristics and treatment of patients with high-grade endometrial stromal sarcoma: A retrospective study of 40 cases. Medicine (Baltimore) 2022;101:e28490. [PMID: 35029198 DOI: 10.1097/MD.0000000000028490] [Reference Citation Analysis]
13 Sousa FAE, Ferreira J, Cunha TM. MR Imaging of uterine sarcomas: a comprehensive review with radiologic-pathologic correlation. Abdom Radiol (NY) 2021;46:5687-706. [PMID: 34468798 DOI: 10.1007/s00261-021-03263-w] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
14 Kostov S, Kornovski Y, Ivanova V, Dzhenkov D, Metodiev D, Watrowski R, Ivanova Y, Slavchev S, Mitev D, Yordanov A. New Aspects of Sarcomas of Uterine Corpus-A Brief Narrative Review. Clin Pract 2021;11:878-900. [PMID: 34842646 DOI: 10.3390/clinpract11040103] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
15 Rebegea LF, Firescu D, Anghel RM, Gales L, Ilie AM, Dumitru ME, Craescu M, Niculet E, Tatu AL, Cretu MS, Lungu M, Neagu AI. Clinical, histological and therapeutical aspects in the management of uterine and extrauterine stromal sarcomas: Case reports. Exp Ther Med 2021;22:1456. [PMID: 34737796 DOI: 10.3892/etm.2021.10891] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
16 Matsukawa H, Ota N, Nishioka K, Noguchi T, Iwahashi N, Mabuchi Y, Yagi S, Minami S, Ino K. Low-grade endometrial stromal sarcoma in a young woman diagnosed after resection of endometrial polyp-like lesions: A case report. Mol Clin Oncol 2021;15:236. [PMID: 34650803 DOI: 10.3892/mco.2021.2400] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
17 Dundr P, Gregová M, Hojný J, Krkavcová E, Michálková R, Němejcová K, Bártů M, Hájková N, Laco J, Mára M, Richtárová A, Zima T, Stružinská I. Uterine cellular leiomyomas are characterized by common HMGA2 aberrations, followed by chromosome 1p deletion and MED12 mutation: morphological, molecular, and immunohistochemical study of 52 cases. Virchows Arch 2021. [PMID: 34626221 DOI: 10.1007/s00428-021-03217-z] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 4.0] [Reference Citation Analysis]
18 Tajiri T, Mima K, Kanemitsu K, Takematsu T, Kosumi K, Inoue M, Mizumoto T, Kubota T, Muto R, Murayama T, Miyanari N, Baba H. Endometrial stromal sarcoma of the sigmoid colon: a case report and literature review. Int Cancer Conf J 2021;10:294-9. [PMID: 34567941 DOI: 10.1007/s13691-021-00493-z] [Reference Citation Analysis]
19 Le Page C, Almadani N, Turashvili G, Bataillon G, Portelance L, Provencher D, Mes-Masson AM, Gilks B, Hoang L, Rahimi K. SATB2 Expression in Uterine Sarcoma: A Multicenter Retrospective Study. Int J Gynecol Pathol 2021;40:487-94. [PMID: 33720083 DOI: 10.1097/PGP.0000000000000730] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
20 Tang Y, Chen Y, Tian L, Chen J, Yang P, Zhang D, Cui Q, Zhao L, Li L. Vaginal Low-Grade Endometrial Stromal Sarcoma: An Extremely Rare Case Report and Review of the Literature. Int J Gynecol Pathol 2020;39:447-51. [PMID: 31569185 DOI: 10.1097/PGP.0000000000000626] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
21 Mori S, Gotoh O, Kiyotani K, Low SK. Genomic alterations in gynecological malignancies: histotype-associated driver mutations, molecular subtyping schemes, and tumorigenic mechanisms. J Hum Genet 2021;66:853-68. [PMID: 34092788 DOI: 10.1038/s10038-021-00940-y] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
22 Engelberg IA, Liu J, Norris-Drouin JL, Cholensky SH, Ottavi SA, Frye SV, Kutateladze TG, James LI. Discovery of an H3K36me3-Derived Peptidomimetic Ligand with Enhanced Affinity for Plant Homeodomain Finger Protein 1 (PHF1). J Med Chem 2021;64:8510-22. [PMID: 33999620 DOI: 10.1021/acs.jmedchem.1c00430] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 5.0] [Reference Citation Analysis]
23 Ou WB, Lundberg MZ, Zhu S, Bahri N, Kyriazoglou A, Xu L, Chen T, Mariño-Enriquez A, Fletcher JA. YWHAE-NUTM2 oncoprotein regulates proliferation and cyclin D1 via RAF/MAPK and Hippo pathways. Oncogenesis 2021;10:37. [PMID: 33947829 DOI: 10.1038/s41389-021-00327-w] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
24 Yoon JY, de Kock L, Stewart CJR, McCluggage WG, Foulkes WD, Clarke BA, Rouzbahman M. Endometrial Stem/Progenitor cell (ES/PC) Marker Expression Profile in Adenosarcoma and Endometrial Stromal Sarcoma. Cancer Treat Res Commun 2021;27:100363. [PMID: 33838572 DOI: 10.1016/j.ctarc.2021.100363] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
25 Sudarshan D, Avvakumov N, Lalonde M, Alerasool N, Joly-beauparlant C, Jacquet K, Mameri A, Lambert J, Rousseau J, Lachance C, Paquet E, Herrmann L, Setty ST, Loehr J, Bernardini MQ, Rouzbahman M, Gingras A, Coulombe B, Droit A, Taipale M, Doyon Y, Côté J. Recurrent chromosomal translocations in sarcomas create a mega-complex that mislocalizes NuA4/TIP60 to Polycomb target loci.. [DOI: 10.1101/2021.03.26.436670] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
26 Beltjens F, Molly D, Bertaut A, Richard C, Desmoulins I, Loustalot C, Charon-Barra C, Courcet E, Bergeron A, Ladoire S, Jankowski C, Boidot R, Arnould L. ER-/PR+ breast cancer: A distinct entity, which is morphologically and molecularly close to triple-negative breast cancer. Int J Cancer 2021;149:200-13. [PMID: 33634878 DOI: 10.1002/ijc.33539] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
27 Kommoss FK, Albers J, Schwab C, Wagner WL, Tromba G, Dullin C. Three-dimensional virtual histology of benign and malignant endometrial stromal neoplasms: a new perspective on why morphology matters. Int J Gynecol Cancer 2021;31:934-5. [PMID: 33504548 DOI: 10.1136/ijgc-2020-002313] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
28 Horn LC, Höhn AK, Denschlag D, Follmann M, Schmidt D. [Interdisciplinary S2k guidelines on the diagnosis and treatment of uterine sarcomas-recommendations for surgical pathology]. Pathologe 2020;41:621-33. [PMID: 32940744 DOI: 10.1007/s00292-020-00826-4] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
29 Moore M, Mccluggage WG. Uterine Endometrial Stromal Tumors With Limited Infiltration: First Report of a Case Series Indicating Potential for Malignant Behavior. International Journal of Gynecological Pathology 2020;39:221-6. [DOI: 10.1097/pgp.0000000000000593] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 9.0] [Reference Citation Analysis]
30 Tanikawa M, Kage H, Kohsaka S, Tatsuno K, Ushiku T, Miyagawa K, Aburatani H, Mano H, Oda K. Cancer Genomic Profiling of Gynecological Malignancies by Todai OncoPanel, a Twin DNA and RNA Panel. Current Human Cell Research and Applications 2021. [DOI: 10.1007/978-981-33-6013-6_3] [Reference Citation Analysis]
31 Zhang H, Hicks DG. Breast and Gynecologic Tumors. Practical Oncologic Molecular Pathology 2021. [DOI: 10.1007/978-3-030-73227-1_5] [Reference Citation Analysis]
32 Hawkins PE, Murphy DJ, Mccormack FX, Wikenheiser-brokamp KA, Mccarthy C. Neoplasms That Present as Multicystic Lung Disease. Diffuse Cystic Lung Diseases 2021. [DOI: 10.1007/978-3-030-63365-3_11] [Reference Citation Analysis]
33 Stewart CJR, McCluggage WG, Chua YJ, Texler M, Rabban JT. Uterine plexiform tumourlets: multifocal and solitary cases with subsets expressing melanocytic markers. Histopathology 2021;78:690-8. [PMID: 33103268 DOI: 10.1111/his.14274] [Reference Citation Analysis]
34 Angelos D, Anastasios L, Dimosthenis M, Roxani D, Alexis P, Konstantinos D. Endometrial stromal sarcoma presented as endometrial polyp: a rare case. Gynecol Surg 2020;17:6. [DOI: 10.1186/s10397-020-01073-4] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
35 Croce S, Hostein I, McCluggage WG. NTRK and other recently described kinase fusion positive uterine sarcomas: A review of a group of rare neoplasms. Genes Chromosomes Cancer 2021;60:147-59. [PMID: 33099837 DOI: 10.1002/gcc.22910] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 7.5] [Reference Citation Analysis]
36 Micci F, Heim S, Panagopoulos I. Molecular pathogenesis and prognostication of "low-grade'' and "high-grade" endometrial stromal sarcoma. Genes Chromosomes Cancer 2021;60:160-7. [PMID: 33099834 DOI: 10.1002/gcc.22907] [Cited by in Crossref: 13] [Cited by in F6Publishing: 16] [Article Influence: 6.5] [Reference Citation Analysis]
37 Plentz TBSF, Candido EC, Dias LF, Toledo MCS, Vale DB, Teixeira JC. Diagnosis, treatment and survival of uterine sarcoma: A retrospective cohort study of 122 cases. Mol Clin Oncol 2020;13:81. [PMID: 33093955 DOI: 10.3892/mco.2020.2151] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
38 Muthukumarana V, Fix DJ, Stolnicu S, Park KJ, Soslow RA, Benayed R, Ladanyi M, Antonescu CR, Chiang S. BCOR Expression in Mullerian Adenosarcoma: A Potential Diagnostic Pitfall. Am J Surg Pathol 2020;44:765-70. [PMID: 32011345 DOI: 10.1097/PAS.0000000000001445] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 7.0] [Reference Citation Analysis]
39 Libertini M, Hallin M, Thway K, Noujaim J, Benson C, van der Graaf W, Jones RL. Gynecological Sarcomas: Molecular Characteristics, Behavior, and Histology-Driven Therapy. Int J Surg Pathol 2021;29:4-20. [PMID: 32909482 DOI: 10.1177/1066896920958120] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
40 Chadchan SB, Maurya VK, Krekeler GL, Jungheim ES, Kommagani R. A Role for Malignant Brain Tumor Domain-Containing Protein 1 in Human Endometrial Stromal Cell Decidualization. Front Cell Dev Biol 2020;8:745. [PMID: 32850854 DOI: 10.3389/fcell.2020.00745] [Reference Citation Analysis]
41 Capozzi VA, Monfardini L, Ceni V, Cianciolo A, Butera D, Gaiano M, Berretta R. Endometrial stromal sarcoma: A review of rare mesenchymal uterine neoplasm. J Obstet Gynaecol Res 2020;46:2221-36. [PMID: 32830415 DOI: 10.1111/jog.14436] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 5.5] [Reference Citation Analysis]
42 Nakamura M, Murakami R, Abiko K, Miyamoto T, Kitawaki Y, Yamaguchi K, Horie A, Hamanishi J, Kodoh E, Baba T, Kido A, Minamiguchi S, Matsumura N, Mandai M. Low-Grade Endometrial Stromal Sarcoma with a Nodule-in-Nodule Appearance in Preoperative Magnetic Resonance Images. Case Rep Obstet Gynecol 2020;2020:8973262. [PMID: 32802534 DOI: 10.1155/2020/8973262] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
43 Hodgson A, Swanson D, Tang S, Dickson BC, Turashvili G. Gene fusions characterize a subset of uterine cellular leiomyomas. Genes Chromosomes Cancer 2020. [PMID: 32677742 DOI: 10.1002/gcc.22888] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
44 Hirsch MS, Watkins J. A Comprehensive Review of Biomarker Use in the Gynecologic Tract Including Differential Diagnoses and Diagnostic Pitfalls. Adv Anat Pathol 2020;27:164-92. [PMID: 31149908 DOI: 10.1097/PAP.0000000000000238] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 5.0] [Reference Citation Analysis]
45 Kommoss FK, Chang KT, Stichel D, Banito A, Jones DT, Heilig CE, Fröhling S, Sahm F, Stenzinger A, Hartmann W, Mechtersheimer G, Sinn HP, Schmidt D, Kommoss F, von Deimling A, Koelsche C. Endometrial stromal sarcomas with BCOR-rearrangement harbor MDM2 amplifications. J Pathol Clin Res 2020;6:178-84. [PMID: 32352245 DOI: 10.1002/cjp2.165] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 7.0] [Reference Citation Analysis]
46 Hensley ML, Chavan SS, Solit DB, Murali R, Soslow R, Chiang S, Jungbluth AA, Bandlamudi C, Srinivasan P, Tap WD, Rosenbaum E, Taylor BS, Donoghue MTA, Hyman DM. Genomic Landscape of Uterine Sarcomas Defined Through Prospective Clinical Sequencing. Clin Cancer Res 2020;26:3881-8. [PMID: 32299819 DOI: 10.1158/1078-0432.CCR-19-3959] [Cited by in Crossref: 31] [Cited by in F6Publishing: 33] [Article Influence: 15.5] [Reference Citation Analysis]
47 Han L, Liu YJ, Ricciotti RW, Mantilla JG. A novel MBTD1-PHF1 gene fusion in endometrial stromal sarcoma: A case report and literature review. Genes Chromosomes Cancer 2020;59:428-32. [PMID: 32237188 DOI: 10.1002/gcc.22845] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 5.5] [Reference Citation Analysis]
48 Shao Y, Liu Q, Shi H, Lu B. Ovarian mucinous tumors with mural nodules: immunohistochemical and molecular analysis of 3 cases. Diagn Pathol 2020;15:35. [PMID: 32290854 DOI: 10.1186/s13000-020-00956-6] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
49 McCluggage WG, Lee CH. YWHAE-NUTM2A/B Translocated High-grade Endometrial Stromal Sarcoma Commonly Expresses CD56 and CD99. Int J Gynecol Pathol 2019;38:528-32. [PMID: 30252726 DOI: 10.1097/PGP.0000000000000554] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 4.5] [Reference Citation Analysis]
50 Hodgson A, Pun C, Djordjevic B, Turashvili G. NTRK-rearranged Cervical Sarcoma: Expanding the Clinicopathologic Spectrum. International Journal of Gynecological Pathology 2021;40:73-7. [DOI: 10.1097/pgp.0000000000000669] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 6.5] [Reference Citation Analysis]
51 Davidson B, Matias-Guiu X, Lax SF. The clinical, morphological, and genetic heterogeneity of endometrial stromal sarcoma. Virchows Arch 2020;476:489-90. [PMID: 31993772 DOI: 10.1007/s00428-020-02762-3] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
52 Ondič O, Bednářová B, Ptáková N, Hájková V, Šteiner P, Šidlová H, Presl J, Bouda J, Alaghehbandan R, Michal M. ZC3H7B-BCOR high-grade endometrial stromal sarcoma may present as myoma nascens with cytoplasmic signet ring cell change. Virchows Arch 2020;476:615-9. [PMID: 31938824 DOI: 10.1007/s00428-020-02744-5] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 5.0] [Reference Citation Analysis]
53 Arias-Stella JA 3rd, Benayed R, Oliva E, Young RH, Hoang LN, Lee CH, Jungbluth AA, Frosina D, Soslow RA, Antonescu CR, Ladanyi M, Chiang S. Novel PLAG1 Gene Rearrangement Distinguishes a Subset of Uterine Myxoid Leiomyosarcoma From Other Uterine Myxoid Mesenchymal Tumors. Am J Surg Pathol 2019;43:382-8. [PMID: 30489320 DOI: 10.1097/PAS.0000000000001196] [Cited by in Crossref: 33] [Cited by in F6Publishing: 23] [Article Influence: 16.5] [Reference Citation Analysis]
54 Kommoss FKF, Stichel D, Schrimpf D, Kriegsmann M, Tessier-Cloutier B, Talhouk A, McAlpine JN, Chang KTE, Sturm D, Pfister SM, Romero-Pérez L, Kirchner T, Grünewald TGP, Buslei R, Sinn HP, Mechtersheimer G, Schirmacher P, Schmidt D, Lehr HA, Sahm F, Huntsman DG, Gilks CB, Kommoss F, von Deimling A, Koelsche C. DNA methylation-based profiling of uterine neoplasms: a novel tool to improve gynecologic cancer diagnostics. J Cancer Res Clin Oncol 2020;146:97-104. [PMID: 31768620 DOI: 10.1007/s00432-019-03093-w] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 7.0] [Reference Citation Analysis]
55 Pradeep A, Sajitha K, Bhat S. Metachronous Sarcomas-a Case Report. Indian J Surg Oncol 2020;11:33-5. [PMID: 33088125 DOI: 10.1007/s13193-019-01005-5] [Reference Citation Analysis]
56 Oliva E, Zaloudek CJ, Soslow RA. Mesenchymal Tumors of the Uterus. In: Kurman RJ, Hedrick Ellenson L, Ronnett BM, editors. Blaustein's Pathology of the Female Genital Tract. Cham: Springer International Publishing; 2019. pp. 535-647. [DOI: 10.1007/978-3-319-46334-6_10] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
57 Zhang Y, Li Y, Huang H, Yang J, Wu M, Jin Y, Pan L. Low-Grade Endometrial Stromal Sarcoma and Uterine Adenosarcoma: A Comparison of Clinical Manifestations and Outcomes. J Cancer 2019;10:3352-60. [PMID: 31293638 DOI: 10.7150/jca.30691] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
58 McCarthy AJ, Clarke BA, McGilvray I, Dickson BC, Khalili K, Chetty R. Metastatic low-grade endometrial stromal sarcoma of uterus presenting as a primary pancreatic tumor: case presentation and literature review. Diagn Pathol 2019;14:30. [PMID: 31010432 DOI: 10.1186/s13000-019-0807-3] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
59 Lee WL, Lee FK, Wang PH. Hormone therapy and low-grade endometrial stromal sarcoma. J Chin Med Assoc 2019;82:445-6. [PMID: 30932941 DOI: 10.1097/JCMA.0000000000000104] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
60 Micci F, Davidson B. Molecular Genetics of Uterine Sarcomas. eLS 2019. [DOI: 10.1002/9780470015902.a0028464] [Reference Citation Analysis]
61 Croce S, Hostein I, Longacre TA, Mills AM, Pérot G, Devouassoux-shisheboran M, Velasco V, Floquet A, Guyon F, Chakiba C, Querleu D, Khalifa E, Mayeur L, Rebier F, Leguellec S, Soubeyran I, Mccluggage WG. Uterine and vaginal sarcomas resembling fibrosarcoma: a clinicopathological and molecular analysis of 13 cases showing common NTRK-rearrangements and the description of a COL1A1-PDGFB fusion novel to uterine neoplasms. Mod Pathol 2019;32:1008-22. [DOI: 10.1038/s41379-018-0184-6] [Cited by in Crossref: 63] [Cited by in F6Publishing: 65] [Article Influence: 21.0] [Reference Citation Analysis]
62 Nagaputra JC, Goh RCH, Kuick CH, Chang KTE, Sittampalam K. ZC3H7B-BCOR high-grade endometrial stromal sarcoma with osseous metaplasia: Unique feature in a recently defined entity. Human Pathology: Case Reports 2019;15:54-8. [DOI: 10.1016/j.ehpc.2018.11.002] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
63 Dickson BC. Beyond Smooth Muscle-Other Mesenchymal Neoplasms of the Uterus. Surg Pathol Clin 2019;12:107-37. [PMID: 30709439 DOI: 10.1016/j.path.2018.10.005] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
64 Zhang YY, Li Y, Qin M, Cai Y, Jin Y, Pan LY. High-grade endometrial stromal sarcoma: a retrospective study of factors influencing prognosis. Cancer Manag Res. 2019;11:831-837. [PMID: 30697075 DOI: 10.2147/cmar.s187849] [Cited by in Crossref: 17] [Cited by in F6Publishing: 19] [Article Influence: 5.7] [Reference Citation Analysis]
65 Rekhtman N, Baine MK, Bishop JA. Immunostains: Solid Tumors. Quick Reference Handbook for Surgical Pathologists 2019. [DOI: 10.1007/978-3-319-97508-5_2] [Reference Citation Analysis]
66 Thiel FC, Halmen S. Low-Grade Endometrial Stromal Sarcoma - a Review. Oncol Res Treat. 2018;41:687-692. [PMID: 30317238 DOI: 10.1159/000494225] [Cited by in Crossref: 35] [Cited by in F6Publishing: 36] [Article Influence: 8.8] [Reference Citation Analysis]
67 Tuyaerts S, Amant F. Endometrial Stromal Sarcomas: A Revision of Their Potential as Targets for Immunotherapy. Vaccines (Basel) 2018;6:E56. [PMID: 30149610 DOI: 10.3390/vaccines6030056] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
68 Dickson BC, Lum A, Swanson D, Bernardini MQ, Colgan TJ, Shaw PA, Yip S, Lee CH. Novel EPC1 gene fusions in endometrial stromal sarcoma. Genes Chromosomes Cancer 2018;57:598-603. [PMID: 30144186 DOI: 10.1002/gcc.22649] [Cited by in Crossref: 28] [Cited by in F6Publishing: 30] [Article Influence: 7.0] [Reference Citation Analysis]
69 Ding J, Li M, Deng L, Li T. Study on Biological Characteristics and Mechanism of Paclitaxel Induced Drug Resistance in Endometrial Carcinoma Cells. Biomed Res Int 2018;2018:8372085. [PMID: 30175145 DOI: 10.1155/2018/8372085] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
70 Michael Straughn J Jr, Boitano T, Smith HJ, Dilley SE, Liang MI, Novak L. Treatment of low-grade endometrial stromal sarcoma in a nulligravid woman. Gynecol Oncol 2018;151:6-9. [PMID: 29887484 DOI: 10.1016/j.ygyno.2018.05.027] [Reference Citation Analysis]
71 Oliva E, Zaloudek CJ, Soslow RA. Mesenchymal Tumors of the Uterus. Blaustein's Pathology of the Female Genital Tract 2018. [DOI: 10.1007/978-1-4614-3165-7_10-2] [Reference Citation Analysis]
72 McCluggage WG, Oliva E. Gynaecological pathology: problematic areas, new concepts and emerging developments. Pathology 2018;50:119-21. [PMID: 29258703 DOI: 10.1016/j.pathol.2017.11.085] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]